TABLE 1.
Patient Sociodemographic and Clinical Characteristics, Overall and Stratified by Occurrence of Surveillance-Related Physical Harm
| Characteristic | All Patients (n = 680) | Patients Without Physical Harm (n = 493) | Patients With Physical Harm (n = 187) | P Value* |
|---|---|---|---|---|
| Age, years | 54.3 ± 9.4 | 54.3 ± 9.7 | 54.3 ± 8.6 | 0.95 |
| Sex (% male) | 440 (64.7) | 316 (64.1) | 124 (66.3) | 0.59 |
| Race/ethnicity | 0.49 | |||
| Non-Hispanic white | 221 (32.5) | 168 (34.1) | 53 (28.4) | |
| Black | 156 (22.9) | 109 (22.1) | 47 (25.1) | |
| Hispanic | 286 (42.1) | 203 (41.2) | 83 (44.4) | |
| Other/unknown | 17 (2.5) | 13 (2.6) | 4 (2.1) | |
| BMI | 0.38 | |||
| <25 | 166 (24.5) | 121 (24.6) | 45 (24.2) | |
| 25.0–29.9 | 225 (33.2) | 161 (32.7) | 64 (34.4) | |
| 30.0–34.9 | 158 (23.3) | 122 (24.8) | 36 (19.4) | |
| ≥35 | 129 (19.0) | 88 (17.9) | 41 (22.0) | |
| Etiology of liver disease | 0.30 | |||
| Hepatitis C | 382 (56.2) | 265 (53.7) | 117 (62.6) | |
| Hepatitis B | 22 (3.2) | 16 (3.3) | 6 (3.2) | |
| Alcohol-related | 175 (25.7) | 135 (27.4) | 40 (21.4) | |
| NASH | 79 (11.6) | 59 (12.0) | 20 (10.7) | |
| Other | 22 (3.2) | 18 (3.6) | 4 (2.1) | |
| Child Pugh class | 0.93 | |||
| A | 203 (29.8) | 148 (30.0) | 55 (29.4) | |
| B | 388 (57.1) | 282 (57.2) | 106 (56.7) | |
| C | 89 (13.1) | 63 (12.8) | 26 (13.9) | |
| Presence of HE (%) | 154 (22.7) | 110 (22.3) | 44 (23.5) | 0.74 |
| Presence of ascites (%) | 270 (39.7) | 204 (41.4) | 66 (35.3) | 0.15 |
| Receipt of hepatology care | 441 (65.5) | 307 (62.7) | 134 (73.2) | 0.01 |
| Platelet count (×109/L) | 110 ± 64 | 114 ± 67 | 103 ± 53 | 0.06 |
| Thrombocytopenia | 522 (78.0) | 362 (74.8) | 160 (86.5) | 0.001 |
| Creatinine (mg/dL) | 1.0 ± 0.8 | 1.1 ± 0.9 | 0.9 ± 0.5 | 0.02 |
| AST (U/L) | 78 ± 72 | 73 ± 64 | 92 ± 89 | 0.002 |
| AST >35 U/L | 564 (83.7) | 399 (81.9) | 165 (88.2) | 0.05 |
| ALT (U/L) | 58 ± 50 | 53 ± 45 | 73 ± 61 | <0.001 |
| ALT >35 U/L | 412 (61.0) | 277 (56.8) | 135 (72.2) | 0.001 |
| Bilirubin (mg/dL) | 1.8 ± 2.6 | 1.9 ± 2.8 | 1.6 ± 2.1 | 0.35 |
| INR | 1.3 ± 0.4 | 1.3 ± 0.5 | 1.3 ± 0.4 | 0.65 |
| No. of HCCs | 78 (11.5) | 63 (12.8) | 15 (8.0) | 0.08 |
*
P value comparing patients with and without any surveillance-related physical harm.